Efficacy and Safety of Salvia miltiorrhiza Extract (SAGX) Compared with Saw Palmetto in Men with Lower Urinary Tract Symptoms: A 12-Week, Randomized, Double-Blind, Parallel-Group Pilot Study
Nutrients · 29.05.2026 · 18 (11) · 1752
DOI: 10.3390/nu18111752 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 29.05.2026. Verfasst von Eun Young Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gangnam Guard Urology Clinic, Seoul 07008, Republic of Korea. Hauptthemen laut MEDLINE: Lower Urinary Tract Symptoms, Plant Extracts, Salvia miltiorrhiza, Serenoa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Curome Biosciences Co., Ltd..
Abstract (Originalsprache)
Background
Lower urinary tract symptoms (LUTS) are prevalent among aging men and negatively affect quality of life. Salvia miltiorrhiza extract (SAGX), which exhibits anti-inflammatory and antioxidant properties, has been developed as a functional ingredient to improve LUTS. However, comparative clinical data against established standards, such as saw palmetto, are currently lacking.
Objectives
To compare the efficacy and safety of SAGX with saw palmetto extract in men with LUTS.
Methods
In this randomized, parallel-group pilot study, 30 men with LUTS were assigned to receive either 400 mg of SAGX or 320 mg of saw palmetto extract once daily for 12 weeks. The primary outcome was the change in the International Prostate Symptom Score (IPSS) and the LUTS-related quality-of-life (QoL) score. Secondary outcomes included changes in the erectile function assessed using the International Index of Erectile Function (IIEF). Safety was evaluated by monitoring adverse events.
Results
SAGX supplementation resulted in a significantly greater reduction in total IPSS compared with the saw palmetto group (p = 0.031), with notable improvements in storage symptoms (p = 0.003) and QoL (p = 0.035). Erectile function also improved significantly in the SAGX group (p = 0.005). All adverse events were mild and transient, with treatment-related events occurring less frequently in the SAGX group.
Conclusions
Although this study was a pilot study with a limited cohort, these findings provide preliminary evidence for the use of SAGX as a functional ingredient for supporting urinary health in men with LUTS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gangnam Guard Urology Clinic, Seoul 07008, Republic of Korea.
- College of Pharmacy, CHA University, Pocheon 11160, Republic of Korea.
- Curome Biosciences Co., Ltd., Suwon 16229, Republic of Korea.
ORCID-Profile: Eun Young Kim, Eun Joo Lee, Joon Young Chang, Sang Jun Im, Ha Young Kim
Förderung
- Curome Biosciences Co., Ltd.
Zitieren
APA
Kim, E. Y., Lee, E. J., Chang, J. Y., Im, S. J., Park, Y. H., & Kim, H. Y. (2026). Efficacy and Safety of Salvia miltiorrhiza Extract (SAGX) Compared with Saw Palmetto in Men with Lower Urinary Tract Symptoms: A 12-Week, Randomized, Double-Blind, Parallel-Group Pilot Study. Nutrients, 18(11), 1752. https://doi.org/10.3390/nu18111752
Vancouver
Kim EY, Lee EJ, Chang JY, Im SJ, Park YH, Kim HY. Efficacy and Safety of Salvia miltiorrhiza Extract (SAGX) Compared with Saw Palmetto in Men with Lower Urinary Tract Symptoms: A 12-Week, Randomized, Double-Blind, Parallel-Group Pilot Study. Nutrients. 2026;18(11):1752. doi:10.3390/nu18111752
BibTeX
@article{Kim2026,
author = {Kim, Eun Young and Lee, Eun Joo and Chang, Joon Young and Im, Sang Jun and Park, Young Ho and Kim, Ha Young},
title = {Efficacy and Safety of Salvia miltiorrhiza Extract (SAGX) Compared with Saw Palmetto in Men with Lower Urinary Tract Symptoms: A 12-Week, Randomized, Double-Blind, Parallel-Group Pilot Study},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {11},
pages = {1752},
doi = {10.3390/nu18111752}
}
EUVIMED